Feedback / Questions
Elayta (zervimesine) - Cognition Therap
https://www.globenewswire.com/news-release/2025/05/08/3077141/0/en/Cognition-Therapeutics-Reports-Topline-Results-Showing-Oral-Zervimesine-CT1812-Reduced-Lesion-Growth-in-Phase-2-Study-in-Geographic-Atrophy.html
May 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next